Jennifer M Connelly
Overview
Explore the profile of Jennifer M Connelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
492
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bovi J, Prah M, Retzlaff A, Schmainda K, Connelly J, Rand S, et al.
Int J Radiat Oncol Biol Phys
. 2020 Jun;
108(4):979-986.
PMID: 32599030
Purpose: Dismal prognosis and limited treatment options for recurrent high-grade glioma have provoked interest in various forms of reirradiation. Pulsed reduced dose rate radiation therapy (pRDR) is a promising technique...
12.
Lee E, Zhang P, Wen P, Gerstner E, Reardon D, Aldape K, et al.
Cancer
. 2020 Mar;
126(12):2821-2828.
PMID: 32154928
Background: Targeting vascular endothelial growth factor (VEGF) alone does not improve overall survival (OS) in recurrent glioblastoma (rGBM). The angiopoiein (Ang)-TIE2 system may play a role in tumor survival under...
13.
Kapke J, Schneidewend R, Jawa Z, Huang C, Connelly J, Chitambar C
Hematol Oncol Stem Cell Ther
. 2019 Oct;
12(4):189-193.
PMID: 31629723
Leptomeningeal metastasis (LM) in breast cancer is associated with significant morbidity and mortality. While there is currently no standard therapy, treatment options include craniospinal radiotherapy, intrathecal chemotherapy and systemic chemotherapy....
14.
Doan N, Alhajala H, Al-Gizawiy M, Mueller W, Rand S, Connelly J, et al.
Oncotarget
. 2018 Jan;
8(68):112662-112674.
PMID: 29348854
Glioblastoma remains the most common, malignant primary cancer of the central nervous system with a low life expectancy and an overall survival of less than 1.5 years. The treatment options...
15.
Prah M, Al-Gizawiy M, Mueller W, Cochran E, Hoffmann R, Connelly J, et al.
J Neurooncol
. 2017 Sep;
136(1):13-21.
PMID: 28900832
The goal of this study is to spatially discriminate tumor from treatment effect (TE), within the contrast-enhancing lesion, for brain tumor patients at all stages of treatment. To this end,...
16.
Doan N, Nguyen H, Al-Gizawiy M, Mueller W, Sabbadini R, Rand S, et al.
Oncol Rep
. 2017 Aug;
38(4):1932-1940.
PMID: 28765947
Glioblastoma multiforme (GBM) is the most common primary, intracranial malignancy of the central nervous system. The standard treatment protocol, which involves surgical resection, and concurrent radiation with adjuvant temozolomide (TMZ),...
17.
Doan N, Nguyen H, Montoure A, Al-Gizawiy M, Mueller W, Kurpad S, et al.
Oncotarget
. 2017 Apr;
8(15):24753-24761.
PMID: 28445970
Pediatric brain tumors are the most common solid tumors in children and are also a leading culprit of cancer-related fatalities in children. Pediatric brain tumors remain hard to treat. In...
18.
Quirk B, Brandal G, Donlon S, Vera J, Mang T, Foy A, et al.
Photodiagnosis Photodyn Ther
. 2015 May;
12(3):530-44.
PMID: 25960361
Introduction: What is the current status of photodynamic therapy (PDT) with regard to treating malignant brain tumors? Despite several decades of effort, PDT has yet to achieve standard of care....
19.
Heroux M, Chesnik M, Halligan B, Al-Gizawiy M, Connelly J, Mueller W, et al.
Physiol Genomics
. 2014 May;
46(13):467-81.
PMID: 24803679
Cancer is a complex disease; glioblastoma (GBM) is no exception. Short survival, poor prognosis, and very limited treatment options make it imperative to unravel the disease pathophysiology. The critically important...
20.
Ellingson B, LaViolette P, Rand S, Malkin M, Connelly J, Mueller W, et al.
Magn Reson Med
. 2011 Mar;
65(4):1131-43.
PMID: 21413079
The purpose of this study was to develop a voxel-wise analytical solution to a glioma growth model using serial diffusion MRI. These cell invasion, motility, and proliferation level estimates (CIMPLE...